- Home
- ET vs BDX Comparison
ET vs BDX Comparison
Compare ET & BDX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ET
- BDX
- Stock Information
- Founded
- ET 2002
- BDX 1897
- Country
- ET United States
- BDX United States
- Employees
- ET N/A
- BDX N/A
- Industry
- ET Natural Gas Distribution
- BDX Medical/Dental Instruments
- Sector
- ET Utilities
- BDX Health Care
- Exchange
- ET Nasdaq
- BDX Nasdaq
- Market Cap
- ET 58.3B
- BDX 68.0B
- IPO Year
- ET 2006
- BDX 1962
- Fundamental
- Price
- ET $18.29
- BDX $222.41
- Analyst Decision
- ET Strong Buy
- BDX Strong Buy
- Analyst Count
- ET 8
- BDX 7
- Target Price
- ET $20.00
- BDX $283.00
- AVG Volume (30 Days)
- ET 17.1M
- BDX 1.6M
- Earning Date
- ET 11-06-2024
- BDX 11-07-2024
- Dividend Yield
- ET 7.08%
- BDX 1.71%
- EPS Growth
- ET 28.29
- BDX N/A
- EPS
- ET 1.36
- BDX 4.84
- Revenue
- ET $83,662,000,000.00
- BDX $19,828,000,000.00
- Revenue This Year
- ET $12.20
- BDX $5.13
- Revenue Next Year
- ET $5.93
- BDX $8.06
- P/E Ratio
- ET $13.45
- BDX $45.91
- Revenue Growth
- ET 6.50
- BDX 4.11
- 52 Week Low
- ET $13.12
- BDX $218.75
- 52 Week High
- ET $18.29
- BDX $249.89
- Technical
- Relative Strength Index (RSI)
- ET 82.38
- BDX 33.52
- Support Level
- ET $17.07
- BDX $220.54
- Resistance Level
- ET $17.71
- BDX $236.00
- Average True Range (ATR)
- ET 0.30
- BDX 5.57
- MACD
- ET 0.11
- BDX -1.28
- Stochastic Oscillator
- ET 96.18
- BDX 7.84
About ET Energy Transfer LP Common Units
Energy Transfer owns a large platform of crude oil, natural gas, and natural gas liquid assets primarily in Texas and the U.S. midcontinent region. It also has gathering and processing facilities, one of the largest fractionation facilities in the U.S., and fuel distribution. Energy Transfer also owns the Lake Charles gas liquefaction facility. It combined its publicly traded limited and general partnerships in October 2018.
About BDX Becton Dickinson and Company
Becton, Dickinson is the world's largest manufacturer and distributor of medical surgical products, such as needles, syringes, and sharps-disposal units. The company also manufactures pre-filled devices, diagnostic instruments and reagents, as well as flow cytometry and cell-imaging systems. BD Medical is nearly half of the total business, while BD Life Sciences (27% of 2023 revenue) and BD Interventional (24%) account for the remainder. International revenue accounts for 43% of the company's business.